Search

Trypanosomiasis, a group of diseases including sleeping sickness in humans and Nagana in cattle in Africa, and Chagas' disease in South America, remains a considerable problem in the 21(st) century. The therapies that are available, however, usually have their roots in the "dye therapy" of a century ago, knowledge gained at the microscope from parasite staining procedures and converted to chemotherapy based on compounds closely related to the laboratory reagents. Dyes such as trypan red and trypan blue led to the development of suramin, while cationic nitrogen heterocyclic dyes furnished examples of the phenanthridinium class, such as ethidium (homidium) and isometamidium. Both suramin and isometamidium remain in use. Owing to mutagenicity issues, the presence of ethidium among the phenanthridinium dyes has led to concerns over the clinical use of related derivatives. There are several mechanisms for dye-DNA interaction, however, including possible hydrogen bonding of dye to the polymer, and these are discussed together with structure-activity relations and cellular localization of the phenanthridine and isomeric acridines involved. Better understanding of nucleic acid binding properties has allowed the preparation of more effective phenanthridinium analogues intended for use as anticancer/antiviral therapy.

As European colonization spread widely over the African continent the health and physical welfare of the African population gained more and more importance to European colonists who concentrated on capitalizing on African human resources for an improved financial and economic outcome of their colonies. This brought tropical medicine to the top of the European colonial agenda and raised the awareness of the threat of infectious diseases, such as the African Trypanosomiasis or so-called sleeping disease. In 1916 a group of scientists from the pharmaceutical company Bayer AG discovered a substance on the base of dye rather than arsenic. The drug was called Bayer 205 and showed outstanding therapeutic effects. It also reduced adverse reactions in people infected with sleeping disease. As Germany had already lost its colonies, the Bayer company--supported by the German government--negotiated with the English and Belgian governments and was allowed to send an expedition to East Africa. During 1921 and 1923 the new drug was tested in English Rhodesia and Belgian Congo and proved revolutionary, especially in comparison with conventional substances. In due course, the drug Bayer 205 was named Germanin and it was subsequently proposed to use it for political leverage: knowledge and use of the new drug was to be given only in exchange for parts of the former German colonies. However, the reactions of the international media put an end to Germany's neo-colonial-dreams, even before the proposal had reached governmental level. Even so, the incident never disappeared from the mind of those who wished to revive German colonialism. Thus, it is no surprise, that the tale of the discovery and perceived "injustice" of a thwarted scientific success regained an important place in National Socialist propaganda. This article will examine two sources to exemplify the role Germanin attained in National Socialist propaganda: Hellmuth Unger's popular science novel Germanin. Geschichte einer deutschen Grosstat and Max Kimmich's movie Germanin. Geschichte einer kolonialen Tat, a film adaption of Unger's book which mainly treats the expedition Friedrich Karl Kleine, a real-life German professor, once lead into Africa. The film mixes political and ideological propaganda with entertaining adventure, lined by an exotic and--when it came to women--rather erotic presentation of the African population.

Trypanosomiasis remains one of the most serious constraints to economic development in sub-Saharan Africa and, as a consequence, related research has been subject to strong social and political as well as scientific influences. The epidemics of sleeping sickness that occurred at the turn of the 20th Century focussed research efforts on what became known as 'the colonial disease'. This focus is thought to have produced 'vertical' health services aimed at this one disease, while neglecting other important health issues. Given the scale of these epidemics, and the fact that the disease is fatal if left untreated, it is unsurprising that sleeping sickness dominated colonial medicine. Indeed, recent evidence indicates that, if anything, the colonial authorities greatly under-estimated the mortality attributable to sleeping sickness. Differences in approach to disease control between Francophone and Anglophone Africa, which in the past have been considered ideological, on examination prove to be logical, reflecting the underlying epidemiological divergence of East and West Africa. These epidemiological differences are ancient in origin, pre-dating the colonial period, and continue to the present day. Recent research has produced control solutions, for the African trypanosomiases of humans and livestock, that are effective, affordable and sustainable by small-holder farmers. Whether these simple solutions are allowed to fulfil their promise and become fully integrated into agricultural practice remains to be seen. After more than 100 years of effort, trypanosomiasis control remains a controversial topic, subject to the tides of fashion and politics.

This paper gives an overview of the treatment of Human African Trypanosomiasis from the early 20th century until today.